Although remission was not improved ( @ % v. @ % ; P = @ ) , posthoc analyses found relapse risk ( RR ) was significantly reduced among GO recipients overall ( @ years : @ % v. @ % ; HzR , @ ; @ % CI , @ to @ ; P = @ ) .